Journal of Literature Pharmacy Sciences

Cordyceps Sinensis (Berk.) Sacc. ve Farmakolojik Açıdan Önemi
Cordyceps Sinensis (Berk.) Sacc. and Its Pharmacological Importance
Alev ÖNDERa, Ahsen Sevde ÇINARa, Meltem CANATANa
aFarmakognozi AD, Ankara Üniversitesi Eczacılık Fakültesi, Ankara, TÜRKİYE
J Lit Pharm Sci. 2019;8(2):85-96
doi: 10.5336/pharmsci.2019-65114
Article Language: TR
Full Text
ÖZET
Cordyceps sinensis, Uzak Doğu'da özellikle Çin, Nepal ve Tibet'in yüksek platolarında yetişen çok değerli ve nadir bulunan tıbbi bir mantardır. Çin'de MS 620'ye kadar uzanan yazılı literatürde; büyülü bir yaratık, hayvan ve bitki olarak tanımlanan tür, Geleneksel Çin Tıbbında yüzyıllardan beri ilaç olarak kullanılmaktadır. Caterpillar fungus, Dong Chong Xia Cao, Çin tırtıl mantarı veya Yarsagumba olarak da bilinen Cordyceps sinensis, taksonomik olarak Ascomycota (keseli mantarlar) sınıfı, Clavicipitaceae familyasında yer alan entomopatojen bir canlı türüdür. Meyveli gövdenin morfolojik özellikleri; hafif silindirik, çubuk şeklinde, renk olarak da sarımsı-turuncu veya kırmızımsı-turuncu renge sahip olarak tanımlanmaktadır. Bu mantar geleneksel olarak ishal, baş ağrısı, öksürük, romatizma, karaciğer ve böbrek hastalıkları, diyabet, yorgunluk gibi hastalıklar için binlerce yıldan beri kullanılmaktadır. Kimyasal içeriğinde bulunan nükleozitler, polisakkaritler, steroller, proteinler, vitaminler, mineraller sayesinde tıbbi olarak antitümör, immünomodülatör, antioksidan, antidiyabetik, cinsel gücü artırıcı, yorgunluk giderici, böbrek ve karaciğer fonksiyonlarını iyileştirici etkiler göstermesinin yanı sıra besin değeri olarak da önemli bir tıbbi mantardır. Kimyasal içeriğine bakıldığında, sahip olduğu nükleozit grubuna ait olan kordisepin ve kordisepik asit başlıca bileşenler olarak öne çıkmaktadır. Cordyceps sinensis, son yıllarda tüm dünyada popüler doğal ürünler arasında yerini almıştır. Özellikle antioksidan ve immünomodülatör etkileri nedeniyle, antitümör olarak kullanımı göze çarpmaktadır. Bu nedenle bu çalışmada, önemli farmakolojik etkilere sahip olan ve tıbbi olarak da kullanılan Cordyceps sinensis hakkında daha detaylı bilgi verilmesi, üzerine yapılmış olan araştırmaların sunulması amaçlanmıştır.

Anahtar Kelimeler: Cordyceps sinensis; Hepialus armoricanus; mantar
ABSTRACT
Cordyceps sinensis is a very precious and rare medicinal fungus that grows in the Far East, especially in China, Nepal, and Tibet on high altitude platelets. According to the literature, since 620 AC in China, the species described as a magical creature, animal and plant, has been used as a medicine in Traditional Chinese Medicine for centuries. Cordyceps sinensis, also known as Caterpillar fungus, Dong Chong Xia Cao, Chinese caterpillar fungus and Yarsagumba. Taxonomically, it is an entomopathogenic species in the Ascomycota class and the Clavicipitaceae family. The morphological features of the fruit body are in the form of a slightly cylindrical, rodshaped. The color is defined as yellowish-orange or reddish-orange. This fungus has traditionally been used for thousands of years for diseases such as diarrhea, headache, cough, rheumatism, liver and kidney diseases, diabetes, and fatigue. The chemical content of the fungus includes nucleosides, polysaccharides, sterols, proteins, vitamins and minerals. These components have both antitumor, immunomodulatory, antioxidant, antidiabetic, sexual potency boosters, relieving fatigue, improving kidney function and liver function, and high nutritional value. In its chemical content, cordycepin and cordycepic acid, which belong to the nucleoside group, are the main components. Cordyceps sinensis has become very popular all over the world in recent years. Recently, using the fungus due to its antitumor effect is prominent and its antioxidant and immunomodulatory effects support this effect. For this reason, the studies conducted on Cordyceps sinensis, which has significant pharmacological effects and medicinal importance, are compiled and presented in this review.

Keywords: Cordyceps sinensis; Hepialus armoricanus; fungus
REFERENCES:
  1. Liu Y, Wang J, Wang W, Zhang H, Zhang X, Han C. The chemical constituents and pharmacological actions of Cordyceps sinensis. Evid Based Complement Alternat Med. 2015;2015:575063. [Crossref ] [PubMed] [PMC]
  2. Baral B. Entomopathogenicity and biological attributes of Himalayan treasured fungus Ophiocordyceps sinensis (Yarsagumba). J Fungi (Basel). 2017;3(1):2-16. [Crossref] [PubMed] [ PMC]
  3. Lo HC, Hsieh C, Lin FY, Hsu TH. Systematic review of the mysterious caterpillar fungus Ophiocordyceps sinensis in Dong-ChongXiaCao (Dōng Chóng Xià Căo) and related bioactive ingredients. J Tradit Complement Med. 2013;3(1):16-32. [Crossref ]
  4. Tsim KWK, Li SP. Cordyceps sinensis a traditional Chinese medicine known as winter-worm summer-grass. Asia Pacific Biotech News. 2005;9(21):1162.
  5. Sharma S. Trade of Cordyceps sinensis from high altitudes of the Indian Himalaya: conservation and biotechnological priorities. Curr Sci. 2004;86(12):1614.
  6. Sung GH, Hywel-Jones NL, Sung JM, LuangsaArd JJ, Shrestha B, Spatafora JW. Phylogenetic classification of Cordyceps and the clavicipitaceous fungi. Stud Mycol. 2007;57:5-59. [Crossref] [PubMed] [PMC]
  7. Zhou X, Gong Z, Su Y, Lin J, Tang K. Cordyceps fungi: natural products, pharmacological functions and developmental products. J Pharm Pharmacol. 2009;61(3):279-91. [Crossref] [PubMed]
  8. Wang L, Zhang WM, Hu B, Chen YQ, Qu LH. Genetic variation of Cordyceps militaris and its allies based on phylogenetic analysis of rDNA ITS sequence data. Fungal Divers. 2008;31: 147-56.
  9. Panda AK, Swain KC. Traditional uses and medicinal potential of Cordyceps sinensis of Sikkim. J Ayurveda Integr Med. 2011;2(1):9-13. [Crossref] [PubMed] [ PMC]
  10. Gu YX, Wang ZS, Li SX. Effect of multiple factors on accumulation of nucleosides and bases in Cordyceps militaris. Food Chem. 2007;102(4):1304-9. [Crossref ]
  11. Lin B, Li S. Cordyceps as an herbal drug. In: Benzie IFF, Wachtel-Galor S, eds. Herbal Medicinal Biomolecular and Clinical Aspects. 2 nd ed. Boca Raton (FL): CRC Press/Taylor & Francis; 2011. p.2-50.
  12. Yue K, Ye M, Lin X, Zhou Z. The artificial cultivation of medicinal Caterpillar Fungus, Ophiocordyceps sinensis (Ascomycetes): a review. Int J Med Mushrooms. 2013;15(5): 425-34. [Crossref] [PubMed]
  13. Holliday J, Cleaver P, Powers ML, Patel D. Analysis of quality and techniques for hybridization of medicinal fungus Cordyceps sinensis (Berk.) Sacc. (Ascomycetes). Int J Med Mushrooms. 2004;6(2):147-60. [Crossref ]
  14. Montvale NJ. PDR for Herbal Medicines. Gruenwald J, Brendler T, Jaenicke C, eds. 2nd ed. Montvale, NJ: Medical Economics Co; 2000. p.858.
  15. Chen S, Li Z, Krochmal R, Abrazado M, Kim W, Cooper C.B. Effect of Cs-4 (Cordyceps sinensis) on exercise performance in healthy older subjects: a double-blind, placebo-controlled trial. J Altern Complement Med. 2010;16(5):585-90. [Crossref] [PubMed] [ PMC]
  16. Zhu JS, Halpern GM, Jones K. The scientific rediscovery of a precious ancient Chinese herbal regimen: Cordyceps sinensis: part I. J Altern Complement Med. 1998;4(4):289-303. [Crossref] [ PubMed]
  17. Chen YC, Chen YH, Pan BS, Chang MM, Huang BM. Functional study of Cordyceps sinensis and cordycepin in male reproduction: a review. J Food Drug Anal. 2017;25(1):197-205. [Crossref] [PubMed]
  18. Tuli HS, Sharma AK, Sandhu SS, Kashyap D. Cordycepin: a bioactive metabolite with therapeutic potential. Life Sci. 2013;93(23):863-9. [Crossref] [PubMed]
  19. Li T, Li W. Impact of polysaccharides from Cordyceps on antifatigue in mice. Sci Res Essay. 2009;4(7):705-9.
  20. Li S, Li P, Ji H. [RP-HPLC determination of ergosterol in natural and cultured Cordyceps]. Chin J Mod Appl Pharm. 2011;18: 297-9.
  21. Kitchawalit S, Kanokmedhakul K, Kanokmedhakul S, Soytong K. A new benzyl ester and ergosterol derivatives from the fungus Gymnoascus reessii. Nat Prod Res. 2014;28(14):1045-51. [Crossref ] [PubMed]
  22. Matsuda H, Akaki J, Nakamura S, Okazaki Y, Kojima H, Tamesada M, et al. Apoptosis-inducing effects of sterols from the dried powder of cultured mycelium of Cordyceps sinensis. Chem Pharm Bull. 2009;57(4):411-4. [Crossref] [PubMed]
  23. Ye M, Hu Z, Fan Y, He L, Xia F, Zou G. Purification and characterization of an acid deoxyribonuclease from the cultured mycelia of Cordyceps sinensis. J Biochem Mol Biol. 2004;37(4):466-73. [Crossref ] [PubMed]
  24. Chioa WF, Chang PC, Chou CJ, Chen CF. Protein constituent contributes to the hypotensive and vasorelaxant activities of Cordyceps sinensis. Life Sci. 2000;66(14): 1369-76. [Crossref ]
  25. Qian GM, Pan GF, Guo JY. Anti-inflammatory and antinociceptive effects of cordymin, a peptide purified from the medicinal mushroom Cordyceps sinensis. Nat Prod Res. 2012;26(24):2358-62. [Crossref ] [PubMed]
  26. Jia JM, Ma XC, Wu CF, Wu LJ, Hu GS. Cordycedipeptide A, a new cyclodipeptide from the culture liquid of Cordyceps sinensis (Berk.) Sacc. Chem Pharm Bull. 2005; 53(5):582-3. [Crossref ] [PubMed]
  27. Jia JM, Tao HH, Feng BM. [Cordyceamides A and B from the culture liquid of Cordyceps sinensis (Berk.) Sacc]. Chem Pharm Bull. 2009;57(1):99-101. [Crossref ] [PubMed]
  28. Yang FQ, Guan J, Li SP. Fast simultaneous determination of 14 nucleosides and nucleobases in cultured Cordyceps using ultra-performance liquid. Talanta. 2007;73(2):269-73. [Crossref] [PubMed]
  29. Li SP, Li P, Dong TT, Tsim KW. Determination of neucleosides in natural Cordyceps sinsensis and cultured Cordyceps mycelia by capillary electrophoresis. Electrophoresis. 2001;22(1):144-50. [Crossref]
  30. Yan F, Wang B, Zhang Y. Polysaccharides from Cordyceps sinensis mycelium ameliorate exhaustive swimming exercise-induced oxidative stress. Pharm Biol. 2014;52(2):157-61. [Crossref] [ PubMed]
  31. Yamaguchi Y, Kagota S, Nakamura K, Shinozuka K, Kunitomo M. Antioxidant activity of the extracts from fruiting bodies of cultured Cordyceps sinensis. Phytother Res. 2000;14(8):647-9. [Crossref]
  32. Yu HM, Wang BS, Huang SC, Duh PD. Comparison of protective effects between cultured Cordyceps militaris and natural Cordyceps sinensis against oxidative damage. J Agric Food Chem. 2006;54(8):3132-8. [Crossref] [PubMed]
  33. Ji DB, Ye J, Li CL, Wang YH, Zhao J, Cai SQ. Antiaging effect of Cordyceps sinensis extract. Phytother Res. 2009;23(1):116-22. [Crossref] [PubMed]
  34. Zhao CS, Yin WT, Wang JY, Zhang Y, Yu H, Cooper R, et al. CordyMax Cs-4 improves glucose metabolism and increases insulin sensitivity in normal rats. J Altern Complement Med. 2002;8(3):309-14. [Crossref ] [PubMed]
  35. Balon TW, Jasman AP, Zhu JS. Fermentation product of Cordyceps sinensis increases wholebody insulin sensitivity in rats. J Altern Complement Med. 2002;8(3):315-23. [Crossref] [PubMed]
  36. Lo HC, Tu ST, Lin KC, Lin SC. The anti-hyper glycemic activity of the fruiting body of Cordyceps in diabetic rats induced by nicotinamide and streptozotocin. Life Sci. 2004;74(23):2897908. [Crossref ] [PubMed]
  37. Ng TB, Wang HX. Pharmacological actions of Cordyceps, a prized folk medicine. J Pharm Pharmacol. 2005;57(2):1509-19. [Crossref] [PubMed]
  38. Wu JY, Zhang QX, Leung PH. Inhibitory effects of ethyl acetate extract of Cordyceps sinensis mycelium on various cancer cells in culture and B16 melanoma in C57BL/6 mice. Phytomedicine. 2007;14(1):43-9. [Crossref ] [PubMed]
  39. Yamaguchi N, Yoshida J, Ren LJ, Chen H, Miyazawa Y, Fujii Y, et al. Augmentation of various immune reactivities of tumor-bearing hosts with extract of Cordyceps sinensis. Biotherapy. 1990;2(3):199-205. [Crossref ] [PubMed]
  40. Nakamura K, Yamaguchi Y, Kagota S, Kwon YM, Shinozuka K, Kunitomo M. Inhibitory effect of Cordyceps sinensis on spontaneous liver metastasis of Lewis lung carcinoma and B16 melanoma cells in syngeneic mice. Jpn J Pharmacol. 1999;79(3):335-41. [Crossref] [PubMed]
  41. Chen J, Zhang W, Lu T, Li J, Zheng Y, Kong L. Morphological and genetic characterization of a cultivated Cordyceps sinensis fungus and its polysaccharide component possessing antioxidant property in H22 tumor-bearing mice. Life Sci. 2006;78(23):2742-8. [Crossref ] [PubMed]
  42. Liu WC, Chuang WL, Tsai ML, Hong JH, McBride WH, Chiang CS. Cordyceps sinensis health supplement enhances recovery from taxol-induced leucopenia. Exp Biol Med. 2008;233(4):447-55. [Crossref] [PubMed] [PMC]
  43. Wang BJ, Won SJ, Yu ZR, Su CL. Free radical scavenging and apoptotic effects of Cordyceps sinensis fractionated by supercritical carbon dioxide. Food Chem Toxicol. 2005;43(4):543-52. [Crossref] [PubMed]
  44. Yoshida J, Takamura S, Yamaguchi N, Ren LJ, Chen H, Koshimura S, et al. Antitumor activity of an extract of Cordyceps sinensis (Berk.) Sacc. against murine tumor cell lines. Jpn J Exp Med. 1989;59(4):157-61.
  45. Nakamura K, Shinozuka K, Yoshikawa N. Anticancer and antimetastatic effects of cordycepin, an active component of Cordyceps sinensis. J Pharmacol Sci. 2015;127(1):53-6. [Crossref] [PubMed] [PMC]
  46. Wong JH, Ng TB, Wang H, Sze SC, Zhang KY, Li Q, et al. Cordymin, an antifungal peptide from the medicinal fungus Cordyceps militaris. Phytomedicine. 2011;18(5):387-92. [Crossref] [PubMed]
  47. Sheng L, Chen J, Li J, Zhang W. An exopolysaccharide from cultivated Cordyceps sinensis and its effects on cytokine expressions of immunocytes. Appl Biochem Biotechnol. 2011; 163(5):669-78. [Crossref ] [PubMed]
  48. Movassagh M, Spatz A, Davoust J, Lebecque S, Romero P, Pittet M, et al. Selective accumulation of mature DC-Lamp+ dendritic cells in tumor sites is associated with efficient T-cellmediated antitumor response and control of metastatic dissemination in melanoma. Cancer Res. 2004;15:64(6):2192-8. [Crossref] [PubMed]
  49. Shahed AR, Kim SI, Shoskes DA. Down-regulation of apoptotic and inflammatory genes by Cordyceps sinensis extract in rat kidney following ischemia/reperfusion. Transplant Proc. 2001;33(6):2986-7. [Crossref ]
  50. Wojcikowski K, Johnson DW, Gobé G. Medicinal herbal extracts--renal friend or foe? Part two: herbal extracts with potential renal benefits. Nephrology. 2004;9(6):400-5. [Crossref] [PubMed]
  51. Zhao-Long W, Xiao-Xia W, Ewi-Ying C. Inhibitory effect of Cordyceps sinensis and Cordyceps militaris on human glomerular mesangial cell proliferation induced by native LDL. Cell Biochem Funct. 2000;18(2):93-7.
  52. Li SP, Yang YQ. Dongchongxiacao. Pharmacological Activity-Based Quality Control of Chinese Herbs. 1st ed. New York: Nova Science Publisher, Inc; 2008. p.139-56.
  53. Sun M, Yang YR, Lu YP, Gao R, Wang L, Wang J, et al. [Clinical study on application of bailing capsule after renal transplantation]. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2004;24(9):808-10.
  54. Hsu CC, Tsai SJ, Huang YL, Huang BM. Regulatory mechanism of Cordyceps sinensis mycelium on mouse Leydig cell steroidogenesis. FEBS Lett. 2003;543(1-3):140-3. [Crossref ]
  55. Taylor AL, Watson CJ, Bradley JA. Immunosuppressive agents in solid organ transplantation: mechanisms of action and therapeutic efficacy. Crit Rev Oncol Hematol. 2005;56(1):23-46. [Crossref ] [PubMed]
  56. Li SP, Tsim KW. The biological and pharmacological properties of Cordyceps sinensis, a traditional Chinese medicine that has broad clinical applications. In: Packer L, Ong CN, Halliwell B, eds. Herbal and Traditional Medicine: Biomolecular and Clinical Aspects. 1st ed. New York: Marcel Dekker; 2004. p.579-605. [Crossref ]
  57. Zhao SL. Advance of treatment for Cordyceps on chronic hepatic diseases. Shanxi Zhong Yi. 2000;16:59-60.
  58. Li FH, Liu P, Xiong WG, Xu GF. [Effects of Cordyceps sinensis on dimethylnitrosamine induced liver fibrosis in rats]. Zhong Xi Yi Jie He Xue Bao. 2006;4(5):514-7. [Crossref] [PubMed]
  59. Chor SY, Hui AY, To KF, Chan KK, Go YY, Chan HL, et al. Anti-proliferative and pro-apoptotic effects of herbal medicine on hepatic stellate cell. J Ethnopharmacol. 2005;100(1-2): 180-6. [Crossref ] [PubMed]
  60. Zeng XK, Tang Y, Yuan SR. The protective effects of CS and CN80-2 against the immunological liver injury in mice. Zhongguo Yao Xue Za Zhi. 2001;36:161-4.
  61. Chaudhuri A, Behan PO. Fatigue in neurological disorders. Lancet. 2004;363(9413):978-88. [Crossref]
  62. Mizuno K, Tanaka M, Nozaki S, Mizuma H, Ataka S, Tahara T, et al. Antifatigue effects of coenzyme Q10 during physical fatigue. Nutrition. 2008;24(4):293-9. [Crossref ] [PubMed]
  63. Koh JH, Kim KM, Kim JM, Song JC, Suh HJ. Antifatigue and antistress effect of the hot-water fraction from mycelia of Cordyceps sinensis. Biol Pharm Bull. 2003;26(5):691-4. [Crossref] [PubMed]
  64. Jung K, Kim IH, Han D. Effect of medicinal plant extracts on forced swimming capacity in mice. J Ethnopharmacol. 2004;93(1):75-81. [Crossref ] [PubMed]
  65. Manabe N, Azuma Y, Sugimoto M, Uchio K, Miyamoto M, Taketomo N, et al. Effects of the mycelial extract of cultured Cordyceps sinensis on in vivo hepatic energy metabolism and blood flow in dietary hypoferric anaemic mice. Br J Nutr. 2000;83(2):197-204. [Crossref ] [PubMed]
  66. Siu KM, Mak DH, Chiu PY, Poon MK, Du Y, Ko KM. Pharmacological basis of ?Yin-nourishing? and ?Yang-invigorating? actions of Cordyceps, a Chinese tonifying herb. Life Sci. 2004;76(4):385-95. [Crossref ] [PubMed]
  67. Nishizawa K, Torii K, Kawasaki A, Katada M, Ito M, Terashita K, et al. Antidepressant-like effect of Cordyceps sinensis in the mouse tail suspension test. Biol Pharm Bull. 2007;30(9):1758-62. [Crossref ] [PubMed]
  68. Colson SN, Wyatt FB, Johnston DL, Autrey LD, FitzGerald YL, Earnest CP. Cordyceps sinensisand Rhodiola rosea-based supplementation in male cyclists and its effect on muscle tissue oxygen saturation. J Strength Cond Res. 2005;19(2):358-63. [Crossref] [PubMed]
  69. Earnest CP, Morss GM, Wyatt F, Jordan AN, Colson S, Church TS, et al. Effects of a commercial herbal-based formula on exercise per formance in cyclists. Med Sci Sports Exerc. 2004;36(3):504-9. [Crossref ] [PubMed]
  70. Herda TJ, Ryan ED, Stout JR, Cramer JT. Effects of a supplement designed to increase ATP levels on muscle strength, power output, and endurance. J Int Soc Sports Nutr. 2008;5:3. [Crossref] [PubMed] [ PMC]
  71. Shi B, Wang Z, Jin H, Chen YW, Wang Q, Qian Y. Immunoregulatory Cordyceps sinensis increases regulatory T cells to Th17 cell ratio and delays diabetes in NOD mice. Int Immunopharmacol. 2009;9(5):582-6. [Crossref ] [PubMed]
  72. Cho HJ, Cho JY, Rhee MH, Kim HS, Lee HS, Park HJ. Inhibitory effects of cordycepin (3?-deoxyadenosine), a component of Cordyceps militaris, on human platelet aggregation induced by thapsigargin. J Microbiol Biotechnol. 2007;17(7):1134-8.
  73. Huang BM, Hsiao KY, Chuang PC, Wu MH, Pan HA, Tsai SJ. Upregulation of steroidogenic enzymes and ovarian 17-beta-estradiol in human granulosa-lutein cells by Cordyceps sinensis mycelium. Biol Reprod. 2004;70(5):1358-64. [Crossref] [PubMed]
  74. Parcell AC, Smith JM, Schulthies SS, Myrer JW, Fellingham G. Cordyceps sinensis (CordyMax Cs-4) supplementation does not improve endurance exercise performance. Int J Sport Nutr Exerc Metab. 2004;14(2):236-42. [Crossref] [PubMed]
  75. Huang Y, Lu J, Zhu B, Wen Q, Jia F, Zeng S, et al. Toxicity study of fermentation Cordyceps mycelia B414. Chin Tradit Pat Med. 1987;10:24-5.

Login



Contact


Ortadoğu Reklam Tanıtım Yayıncılık Turizm Eğitim İnşaat Sanayi ve Ticaret A.Ş.

.: Address

Turkocagi Caddesi No:30 06520 Balgat / ANKARA
Phone: +90 312 286 56 56
Fax: +90 312 220 04 70
E-mail: info@turkiyeklinikleri.com

.: Manuscript Editing Department

Phone: +90 312 286 56 56/ 2
E-mail: yaziisleri@turkiyeklinikleri.com

.: English Language Redaction

Phone: +90 312 286 56 56/ 145
E-mail: tkyayindestek@turkiyeklinikleri.com

.: Marketing Sales-Project Department

Phone: +90 312 286 56 56/ 142
E-mail: reklam@turkiyeklinikleri.com

.: Subscription and Public Relations Department

Phone: +90 312 286 56 56/ 118
E-mail: abone@turkiyeklinikleri.com

.: Customer Services

Phone: +90 312 286 56 56/ 118
E-mail: satisdestek@turkiyeklinikleri.com

1. TERMS OF USE

1.1. To use the web pages with http://www.turkiyeklinikleri.com domain name or the websites reached through the sub domain names attached to the domain name (They will be collectively referred as "SITE"), please read the conditions below. If you do not accept these terms, please cease to use the "SITE." "SITE" owner reserves the right to change the information on the website, forms, contents, the "SITE," "SITE" terms of use anytime they want.

1.2. The owner of the "SITE" is Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. (From now on it is going to be referred as "Turkiye Klinikleri", shortly) and it resides at Turkocagi cad. No:30, 06520 Balgat Ankara. The services in the "SITE" are provided by "Turkiye Klinikleri."

1.3. Anyone accessing the "SITE" with or without a fee whether they are a natural person or a legal identity is considered to agree these terms of use. In this contract hereby, "Turkiye Klinikleri" may change the stated terms anytime. These changes will be published in the "SITE" periodically and they will be valid when they are published. Any natural person or legal identity benefiting from and reaching to the "SITE" are considered to be agreed to any change on hereby contract terms done by "Turkiye Klinikleri."

1.4. The "Terms of Use" hereby is published in the website with the last change on March 30th 2014 and the "SITE" is activated by enabling the access to everyone. The "Terms of Use" hereby is also a part of the any "USER Contract" was and/or will be done with the users using "Turkiye Klinikleri" services with or without a fee an inseparable.

2. DEFINITIONS

2.1. "SITE": A website offering different kind of services and context with a certain frame determined by "Turkiye Klinikleri" and it is accessible on-line on http://www.turkiyeklinikleri.com domain name and/or subdomains connected to the domain name.

2.2. USER: A natural person or a legal identity accessing to the "SITE" through online settings.

2.3. LINK: A link enabling to access to another website through the "SITE", the files, the context or through another website to the "SITE", the files and the context.

2.4. CONTEXT: Any visual, literary and auditory images published in the "Turkiye Klinikleri", "SITE" and/or any website or any accessible information, file, picture, number/figures, price, etc.

2.5. "USER CONTRACT": An electronically signed contract between a natural or a legal identity benefiting from special services "Turkiye Klinikleri" will provide and "Turkiye Klinikleri".

3. SCOPE OF THE SERVICES

3.1. "Turkiye Klinikleri" is completely free to determine the scope and quality of the services via the "SITE".

3.2. To benefit the services of "Turkiye Klinikleri" "SITE", the "USER" must deliver the features that will be specified by "Turkiye Klinikleri". "Turkiye Klinikleri" may change this necessity any time single-sided.

3.3. Not for a limited number, the services "Turkiye Klinikleri" will provide through the "SITE" for a certain price or for free are;

- Providing scientific articles, books and informative publications for health industry.

- Providing structural, statistical and editorial support to article preparation stage for scientific journals.

4. GENERAL PROVISIONS

4.1. "Turkiye Klinikleri" is completely free to determine which of the services and contents provided in the "SITE" will be charged.

4.2. People benefiting from the services provided by "Turkiye Klinikleri" and using the website can use the "SITE" only according to the law and only for personal reasons. Users have the criminal and civil liability for every process and action they take in the "SITE". Every USER agrees, declares and undertakes that they will not proceed by any function or action infringement of rights of "Turkiye Klinikleri"s and/or other third parties', they are the exclusive right holder on usage, processing, storage, made public and revealing any written, visual or auditory information reported to Turkiye Klinikleri" and/or "SITE" to the third parties. "USER" agrees and undertakes that s/he will not duplicate, copy, distribute, process, the pictures, text, visual and auditory images, video clips, files, databases, catalogs and lists within the "SITE", s/he will not be using these actions or with other ways to compete with "Turkiye Klinikleri", directly or indirectly.

4.3. The services provided and the context published within the "SITE" by third parties is not under the responsibility of "Turkiye Klinikleri", institutions collaborated with "Turkiye Klinikleri", "Turkiye Klinikleri" employee and directors, "Turkiye Klinikleri" authorized salespeople. Commitment to accuracy and legality of the published information, context, visual and auditory images provided by any third party are under the full responsibility of the third party. "Turkiye Klinikleri" does not promise and guarantee the safety, accuracy and legality of the services and context provided by a third party.

4.4. "USER"s cannot act against "Turkiye Klinikleri", other "USER"s and third parties by using the "SITE". "Turkiye Klinikleri" has no direct and/or indirect responsibility for any damage a third party suffered or will suffer regarding "USER"s actions on the "SITE" against the rules of the hereby "Terms of Use" and the law.

4.5. "USER"s accept and undertake that the information and context they provided to the "SITE" are accurate and legal. "Turkiye Klinikleri" is not liable and responsible for promising and guaranteeing the verification of the information and context transmitted to "Turkiye Klinikleri" by the "USER"s, or uploaded, changed and provided through the "SITE" by them and whether these information are safe, accurate and legal.

4.6. "USER"s agree and undertake that they will not perform any action leading to unfair competition, weakening the personal and commercial credit of "Turkiye Klinikleri" and a third party,  encroaching and attacking on personal rights within the "SITE" in accordance with the Turkish Commercial Code Law.

4.7. "Turkiye Klinikleri" reserves the right to change the services and the context within the "SITE"  anytime. "Turkiye Klinikleri" may use this right without any notification and timelessly. "USER"s have to make the changes and/or corrections "Turkiye Klinikleri" required immediately. Any changes and/or corrections that are required by "Turkiye Klinikleri", may be made by "Turkiye Klinikleri" when needed. Any harm, criminal and civil liability resulted or will result from changes and/or corrections required by "Turkiye Klinikleri" and were not made on time by the "USER"s belongs completely to the users.

4.8. "Turkiye Klinikleri" may give links through the "SITE" to other websites and/or "CONTEXT"s and/or folders that are outside of their control and owned and run by third parties. These links are provided for ease of reference only and do not hold qualification for support the respective web SITE or the admin or declaration or guarantee for the information inside. "Turkiye Klinikleri" does not hold any responsibility over the web-sites connected through the links on the "SITE", folders and context, the services or products on the websites provided through these links or their context.

4.9. "Turkiye Klinikleri" may use the information provided to them by the "USERS" through the "SITE" in line with the terms of the "PRIVACY POLICY" and "USER CONTRACT". It may process the information or classify and save them on a database. "Turkiye Klinikleri" may also use the USER's or visitor's identity, address, e-mail address, phone number, IP number, which sections of the "SITE" they visited, domain type, browser type, date and time information to provide statistical evaluation and customized services.

5. PROPRIETARY RIGHTS

5.1. The information accessed through this "SITE" or provided by the users legally and all the elements (including but not limited to design, text, image, html code and other codes) of the "SITE" (all of them will be called as studies tied to "Turkiye Klinikleri"s copyrights) belongs to "Turkiye Klinikleri". Users do not have the right to resell, process, share, distribute, display or give someone permission to access or to use the "Turkiye Klinikleri" services, "Turkiye Klinikleri" information and the products under copyright protection by "Turkiye Klinikleri". Within hereby "Terms of Use" unless explicitly permitted by "Turkiye Klinikleri" nobody can reproduce, process, distribute or produce or prepare any study from those under "Turkiye Klinikleri" copyright protection.

5.2. Within hereby "Terms of Use", "Turkiye Klinikleri" reserves the rights for "Turkiye Klinikleri" services, "Turkiye Klinikleri" information, the products associated with "Turkiye Klinikleri" copyrights, "Turkiye Klinikleri" trademarks, "Turkiye Klinikleri" trade looks or its all rights for other entity and information it has through this website unless it is explicitly authorized by "Turkiye Klinikleri".

6. CHANGES IN THE TERMS OF USE

"Turkiye Klinikleri" in its sole discretion may change the hereby "Terms of Use" anytime announcing within the "SITE". The changed terms of the hereby "Terms of Use" will become valid when they are announced. Hereby "Terms of Use" cannot be changed by unilateral declarations of users.

7. FORCE MAJEURE

"Turkiye Klinikleri" is not responsible for executing late or never of this hereby "Terms of Use", privacy policy and "USER Contract" in any situation legally taken into account as force majeure. Being late or failure of performance or non-defaulting of this and similar cases like this will not be the case from the viewpoint of "Turkiye Klinikleri", and "Turkiye Klinikleri" will not have any damage liability for these situations. "Force majeure" term will be regarded as outside of the concerned party's reasonable control and any situation that "Turkiye Klinikleri" cannot prevent even though it shows due diligence. Also, force majeure situations include but not limited to natural disasters, rebellion, war, strike, communication problems, infrastructure and internet failure, power cut and bad weather conditions.

8. LAW AND AUTHORISATION TO FOLLOW

Turkish Law will be applied in practicing, interpreting the hereby "Terms of Use" and managing the emerging legal relationships within this "Terms of Use" in case of finding element of foreignness, except for the rules of Turkish conflict of laws. Ankara Courts and Enforcement Offices are entitled in any controversy happened or may happen due to hereby contract.

9. CLOSING AND AGREEMENT

Hereby "Terms of Use" come into force when announced in the "SITE" by "Turkiye Klinikleri". The users are regarded to agree to hereby contract terms by using the "SITE". "Turkiye Klinikleri" may change the contract terms and the changes will be come into force by specifying the version number and the date of change on time it is published in the "SITE".

 

30.03.2014

Privacy Policy

We recommend you to read the terms of use below before you visit our website. In case you agree these terms, following our rules will be to your favor. Please read our Terms of Use thoroughly.

www.turkiyeklinikleri.com website belongs to Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. and is designed in order to inform physicians in the field of health

www.turkiyeklinikleri.com cannot reach to user’s identity, address, service providers or other information. The users may send this information to the website through forms if they would like to. However, www.turkiyeklinikleri.com may collect your hardware and software information. The information consists of your IP address, browser type, operating system, domain name, access time, and related websites. www.turkiyeklinikleri.com cannot sell the provided user information (your name, e-mail address, home and work address, phone number) to the third parties, publish it publicly, or keep it in the website. Gathered information has a directing feature to be a source for the website’s visitor profile, reporting and promotion of the services.

www.turkiyeklinikleri.com uses the taken information:

-To enhance, improve and maintain the quality of the website

-To generate visitor’s profile and statistical data

-To determine the tendency of the visitors on using our website

-To send print publications/correspondences

-To send press releases or notifications through e-mail

-To generate a list for an event or competition

By using www.turkiyeklinikleri.com you are considered to agree that;

-Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. cannot be hold responsible for any user’s illegal and immoral behavior,

-Terms of use may change from time to time,

-It is not responsible for other websites’ contents it cannot control or the harms they may cause although it uses the connection they provided.

Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. may block the website to users in the following events:

-Information with wrong, incomplete, deceiving or immoral expressions is recorded to the website,

-Proclamation, advertisement, announcement, libelous expressions are used against natural person or legal identity,

-During various attacks to the website,

-Disruption of the website because of a virus.

Written, visual and audible materials of the website, including the code and the software are under protection by legal legislation.

Without the written consent of Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. the information on the website cannot be downloaded, changed, reproduced, copied, republished, posted or distributed.

All rights of the software and the design of the website belong to Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc.

Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. will be pleased to hear your comments about our terms of use. Please share the subjects you think may enrich our website or if there is any problem regarding our website.

info@turkiyeklinikleri.com